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Association of lymph-node 
antigens with lower Gag-specific 
central-memory and higher Env-
specific effector-memory CD8+ 
T-cell frequencies in a macaque 
AIDS model
Hiroshi Ishii1, Saori Matsuoka1, Takushi Nomura1,2, Midori Nakamura1, Teiichiro Shiino1, 
Yuko Sato3, Naoko Iwata-Yoshikawa3, Hideki Hasegawa3, Kazuta Mizuta4, Hiromi Sakawaki4, 
Tomoyuki Miura4, Yoshio Koyanagi4, Taeko K. Naruse5, Akinori Kimura5 & Tetsuro Matano1,6
Virus-specific CD8+ T cells exert strong suppressive pressure on human/simian immunodeficiency virus 
(HIV/SIV) replication. These responses have been intensively examined in peripheral blood mononuclear 
cells (PBMCs) but not fully analyzed in lymph nodes (LNs), where interaction between CD8+ T cells 
and HIV/SIV-infected cells occurs. Here, we investigated target antigen specificity of CD8+ T cells in 
LNs in a macaque AIDS model. Analysis of virus antigen-specific CD8+ T-cell responses in the inguinal 
LNs obtained from twenty rhesus macaques in the chronic phase of SIV infection showed an inverse 
correlation between viral loads and frequencies of CD8+ T cells with CD28+ CD95+ central memory 
phenotype targeting the N-terminal half of SIV core antigen (Gag-N). In contrast, analysis of LNs but 
not PBMCs revealed a positive correlation between viral loads and frequencies of CD8+ T cells with 
CD28−CD95+ effector memory phenotype targeting the N-terminal half of SIV envelope (Env-N), 
soluble antigen. Indeed, LNs with detectable SIV capsid p27 antigen in the germinal center exhibited 
significantly lower Gag-N-specific CD28+ CD95+ CD8+ T-cell and higher Env-N-specific CD28−CD95+ 
CD8+ T-cell responses than those without detectable p27. These results imply that core and envelope 
antigen-specific CD8+ T cells show different patterns of interactions with HIV/SIV-infected cells.
CD8+ T-cell responses directed against varieties of viral antigens are induced following human immunodefi-
ciency virus (HIV) infection. These CD8+ T cells play a central role in the resolution from acute-phase viremia1–4 
but mostly permit persistent HIV replication, leading to AIDS progression. High-frequency CD8+ T cells 
observed in the chronic phase of HIV infection are not sufficient for virus control5–7, and highly effective CD8+ 
T cells are considered important for prevention of disease progression. Several human leukocyte antigen (HLA) 
or major histocompatibility complex class I (MHC-I) alleles are known to be associated with effective CD8+ 
T-cell responses and lower viral loads in HIV infection8–11. Furthermore, previous vaccine trials in macaque 
AIDS models have shown possible reduction in post-challenge viral loads by induction of effective CD8+ T-cell 
responses12–15. These imply that HIV replication may be controlled by potent CD8+ T-cell responses16.
Individual viral proteins show different kinetics of expression and degradation, which can affect efficiency of 
protein-derived epitope presentation to CD8+ T cells. Thus, some viral proteins may be the targets for effective 
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CD8+ T cells frequently, but others not. Analysis of HIV controllers possessing protective HLA class I alleles 
such as HLA-B*27 and HLA-B* 57 found potent CD8+ T-cell responses targeting HIV core Gag epitopes (such 
as HLA-B* 27-restricted Gag263–272 KK10 and HLA-B* 57-restricted Gag240–249 TW10) contributing to HIV con-
trol17–19. Studies in macaque AIDS models have indicated simian immunodeficiency virus (SIV) control by Gag 
antigen-specific CD8+ T-cell responses12,20,21. In addition to these studies on HIV/SIV controllers, analysis in a 
large cohort of HIV-infected individuals showed that Gag-specific CD8+ T-cell responses are associated with 
lower viral loads22–24.
Understanding of the target protein profiles of effective CD8+ T cells are important in the development of an 
intervention strategy toward HIV-1 control. Virus-specific CD8+ T-cell responses have been examined inten-
sively in peripheral blood but not fully analyzed in lymph nodes (LNs) where interaction between CD8+ T cells 
and virus-infected cells occurs, although several studies investigated those in LNs (refs 25 and 26). In the present 
study, we investigated target antigen profiles of LN-derived CD8+ T cells in the chronic phase of SIV infec-
tion in rhesus macaques. Our analysis indicated that viral loads were correlated inversely with SIV core Gag 
antigen-specific central-memory but positively with SIV envelope (Env) antigen-specific effector-memory CD8+ 
T-cell frequencies in LNs.
Results
CD8+ T-cell responses targeting individual SIV antigens in LNs. We examined SIV antigen-specific 
CD8+ T-cell responses in the inguinal LNs and PBMCs obtained from twenty rhesus macaques in the chronic 
phase of SIV infection (Fig. 1). We used animals with varieties of MHC-I haplotypes because MHC-I genotypes 
are associated with target antigens for CD8+ T cells. The twenty macaques were consisting of thirteen unvacci-
nated including both non-controllers and controllers and seven vaccinated also including both non-controllers 
and controllers.
All the macaques showed detectable SIV Nef antigen-specific CD8+ T-cell responses in the LNs. CD8+ T-cell 
responses targeting the N-terminal half of SIV Gag (Gag-N), SIV Vif and the N-terminal half of SIV Env (Env-N) 
antigens were detected in seventeen or eighteen animals, whereas responses specific for other SIV antigens were 
detectable in less animals.
Correlation analyses (Fig. 2) showed no association between plasma viral loads and whole SIV antigen-specific 
CD8+ T-cell frequencies (the sum of Gag-N-, Gag-C-, Pol-N-, Pol-C-, Vif-, Vpx-, Vpr-, Env-N-, Env-C-, Tat-, 
Rev-, and Nef-specific CD8+ T-cell frequencies) in the LNs in the chronic phase. However, we found an inverse 
correlation between viral loads and Gag-N-specific CD8+ T-cell frequencies (p = 0.0072, r = − 0.5813 by 
Spearman’s test). In contrast, Env-N-specific CD8+ T-cell frequencies were positively correlated with viral loads 
(p = 0.0102, r = 0.5602). No significant correlation was observed between viral loads and frequencies of CD8+ T 
cells targeting other SIV antigens in LNs.
We also examined SIV antigen-specific CD8+ T-cell responses in peripheral blood mononuclear cells (PBMCs) 
of these animals (Fig. 3). We confirmed an inverse correlation between viral loads and Gag-N-specific CD8+ 
T-cell frequencies (p = 0.0079, r = − 0.5755), but no significant correlation was observed between viral loads and 
Env-N-specific CD8+ T-cell frequencies in PBMCs. In addition, viral loads were inversely correlated with Vif- 
and Nef-specific CD8+ T-cell frequencies in PBMCs, respectively (Vif: p = 0.0067, r = − 0.5855; Nef: p = 0.0145, 
r = − 0.5376). An inverse correlation was also observed between viral loads and whole SIV antigen-specific CD8+ 
T-cell frequencies (p = 0.0442, r = − 0.4544), which may reflect above inverse correlations between viral loads and 
Gag-N/Vif/Nef-specific CD8+ T-cell frequencies in PBMCs.
Central memory and effector memory subsets of SIV antigen-specific CD8+ T cells in LNs. 
To see the basis of above observations, we investigated frequencies of CD28+ CD95+ (central memory) and 
CD28−CD95+ (effector memory) subsets of SIV antigen-specific CD8+ T cells in the LNs (Fig. S1a, which 
shows a representative gating schema for flow cytometric analysis). In LNs, the majority of SIV antigen-specific 
CD8+ T cells were CD28+ CD95+. However, CD28−CD95+ subsets in Env-N-specific CD8+ T cells were fre-
quently observed. A positive correlation between viral loads and CD28−CD95+ subset frequencies in whole SIV 
antigen-specific CD8+ T cells was observed (p = 0.0449, r = 0.4530 by Spearman’s test) (Fig. S1b). We also exam-
ined frequencies of CD28+ CD95+ and CD28−CD95+ subsets of SIV antigen-specific CD8+ T cells in PBMCs, but 
no significant correlation was observed between viral loads and CD28−CD95+ subset frequencies in whole SIV 
antigen-specific CD8+ T cells in PBMCs (Fig. S1b).
Correlation analyses showed an inverse correlation between plasma viral loads and Gag-N-specific CD28+ 
CD95+ (central memory) CD8+ T-cell frequencies in the LNs (p = 0.0042, r = − 0.6115) (Fig. 4a). No significant 
correlation was observed between viral loads and Gag-N-specific CD28−CD95+ CD8+ T-cell frequencies. In 
contrast, we found a strong positive correlation between viral loads and Env-N-specific CD28−CD95+ (effector 
memory) CD8+ T-cell frequencies in the LNs (p = 0.0009, r = 0.6833), while no correlation was observed between 
viral loads and Env-N-specific CD28+ CD95+ CD8+ T-cell frequencies (Fig. 4a). In addition, viral loads were 
inversely correlated with Vif-specific CD28+ CD95+ CD8+ T-cell frequencies (p = 0.0257, r = − 0.4972) (Fig. S2). 
No significant correlation was observed between viral loads and frequencies of CD28−CD95+ or CD28+ CD95+ 
CD8+ T cells targeting other SIV antigens.
Viral loads were also inversely correlated with Gag-N-specific CD28+ CD95+ CD8+ T-cell frequencies in 
PBMCs (p = 0.0026, r = − 0.6356) (Fig. 4b). Remarkably, no correlation was observed between viral loads and 
Env-N-specific CD28−CD95+ or CD28+ CD95+ CD8+ T-cell frequencies in PBMCs (Fig. 4b). Furthermore, viral 
loads were inversely correlated with Vif- and Nef-specific CD28+ CD95+ CD8+ T-cell frequencies in PBMCs, 
respectively (Vif: p = 0.0315, r = − 0.4818; Nef: p = 0.0343, r = − 0.4750) (Fig. S3). An inverse correlation was also 
observed between viral loads and whole SIV antigen-specific CD28+ CD95+ CD8+ T-cell frequencies (p = 0.0097, 
r = − 0.5632).
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Figure 1. Macaques used in this study and SIV antigen-specific CD8+ T-cell responses in the chronic phase 
of SIV infection. (a) List of twenty macaques used in this study. Determined MHC-I haplotypes in individual 
animals are shown. Thirteen animals were unvaccinated. MHC-I haplotype A+ animals #14, #15, and #16 
received a DNA-prime/SeV-boost vaccine eliciting Gag241–249-specific CD8+ T-cell responses. A+ animal #17 
received a DNA-prime/SeV-boost eliciting Gag206–216-specific CD8+ T-cell responses. Animals #18, #19, and  
#20 received a DNA-prime/SeV-Gag-boost. Animal #18 was challenged with an SIV carrying five gag 
mutations20, while all other animals were infected with the wild-type SIVmac239. Plasma viral loads at 
euthanasia (at indicated months post-infection [pi]) are shown. Viral loads in macaques #4, #5, and #11 were 
previously described38,41. Results on immunohistochemistry analysis to detect SIV p27 antigen in the inguinal 
LNs obtained at euthanasia are also shown. ND, not determined. (b) SIV individual antigen-specific CD8+ 
T-cell responses in the twenty macaques at euthanasia. Frequencies of CD8+ T cells (% of CD8+ T cells) 
targeting Gag-N, Gag-C, Pol-N, Pol-C, Vif, Vpx, Vpr, Env-N, Env-C, Tat, Rev, and Nef, respectively in the 
inguinal LNs (upper panel) and PBMCs (lower panel) are shown.
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Above analyses were performed by using twenty SIV-infected animals consisting of thirteen unvaccinated and 
seven vaccinated. We then examined whether above results can be confirmed by using only the former unvacci-
nated animals. In the analyses using thirteen unvaccinated animals, plasma viral loads were inversely correlated 
with Gag-N-specific CD28+ CD95+ (central memory) CD8+ T-cell frequencies (p = 0.0329, r = − 0.5810) and 
positively correlated with Env-N-specific CD28−CD95+ (effector memory) CD8+ T-cell frequencies in the LNs 
(p = 0.0112, r = 0.6964) (Fig. S4). No significant correlation was observed between viral loads and frequencies of 
Gag-N-specific CD28−CD95+ CD8+ T cells or Env-N-specific CD28+ CD95+ CD8+ T cells. These are consistent 
with the results obtained from the twenty macaques that are shown in Fig. 4a.
Figure 2. Correlation analyses between plasma viral loads and SIV antigen-specific CD8+ T-cell 
frequencies in LNs. Correlation was analyzed between viral loads and frequencies of CD8+ T cells targeting 
Gag-N, Gag-C, Pol-N, Pol-C, Vif, Vpx, Vpr, Env-N, Env-C, Tat, Rev, Nef, or whole SIV antigens in the inguinal 
LNs in the chronic phase of SIV infection. Viral loads were inversely correlated with Gag-N-specific CD8+ 
T-cell frequencies (p = 0.0072, r = − 0.5813 by Spearman’s test) and positively correlated with Env-N-specific 
CD8+ T-cell frequencies (p = 0.0102, r = 0.5602), as shown in the top two panels.
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Finally, we examined SIV Gag capsid p27 antigen in the LNs derived from sixteen animals by immunos-
taining. In nine of them, the p27 was clearly detected in the germinal center but not in the paracortical area 
(Fig. 5a). The antigen was detectable in most of the animals with more than 1.0 × 104 copies/ml of plasma viral 
loads except for animal #1, but undetectable in those with less than 1.0 × 104 copies/ml except for animal #7 
(Fig. 1a). Comparison of T-cell responses showed significantly higher Gag-N-specific CD28+ CD95+ CD8+ T-cell 
Figure 3. Correlation analyses between plasma viral loads and SIV antigen-specific CD8+ T-cell 
frequencies in PBMCs. Correlation was analyzed between viral loads and frequencies of CD8+ T cells targeting 
Gag-N, Gag-C, Pol-N, Pol-C, Vif, Vpx, Vpr, Env-N, Env-C, Tat, Rev, Nef, or whole SIV antigens in PBMCs in the 
chronic phase of SIV infection. Viral loads were inversely correlated with Gag-N-, Vif-, and Nef-specific CD8+ 
T-cell frequencies, respectively (p = 0.0079, r = − 0.5755 on Gag-N; p = 0.0067, r = − 0.5855 on Vif; p = 0.0145, 
r = − 0.5376 on Nef by Spearman’s test). A marginal inverse correlation was also observed between viral loads 
and whole SIV antigen-specific CD8+ T-cell frequencies (p = 0.0442, r = − 0.4544). No significant correlation 
was observed between viral loads and Env-N-specific CD8+ T-cell frequencies.
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Figure 4. Correlation analyses between plasma viral loads and Gag-N- or Env-N-specific CD28− or CD28+ 
CD95+ CD8+ T−cell frequencies. (a) Correlation analyses between viral loads and Gag-N- or Env-N-specific 
CD28− or CD28+ CD95+ CD8+ T-cell frequencies in the inguinal LNs. Viral loads were inversely correlated 
with Gag-N-specific CD28+ CD95+ CD8+ T-cell frequencies (p = 0.0042, r = − 0.6115 by Spearman’s test) and 
positively correlated with Env-N-specific CD28−CD95+ CD8+ T-cell frequencies (p = 0.0009, r = 0.6833). (b) 
Correlation analyses between viral loads and Gag-N- or Env-N-specific CD28− or CD28+ CD95+ CD8+ T-cell 
frequencies in PBMCs. Viral loads were inversely correlated with Gag-N-specific CD28+ CD95+ CD8+ T-cell 
frequencies (p = 0.0026, r = − 0.6356 by Spearman’s test). No significant correlation was observed between viral 
loads and Env-N-specific CD28−CD95+ CD8+ T-cell frequencies.
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frequencies in the LNs without detectable p27 than those with detectable p27 (p = 0.0323 by Mann-Whitney 
U-test) (Fig. 5b). In contrast, Env-N-specific CD28−CD95+ CD8+ T-cell frequencies were significantly higher 
in the LNs with detectable p27 (p = 0.0086) (Fig. 5b). Indeed, Gag-N-specific CD28+ CD95+ CD8+ T cells were 
positive in all the LNs without detectable p27, whereas Env-N-specific CD28−CD95+ CD8+ T cells were positive 
in all the p27-positive LNs but negative in six of the seven p27-negative LNs.
Discussion
Cumulative studies have indicated strong suppressive pressure on HIV-1 replication by Gag-specific CD8+ T 
cells9,27–30. An inverse correlation between plasma viral loads and Gag-specific CD8+ T-cell responses in PBMCs 
was previously shown by a large cohort of HIV-1-infected individuals22–24. The present study found that viral 
loads were inversely correlated with Gag-N-specific CD8+ T-cell frequencies even in the inguinal LNs in a 
macaque AIDS model. Further analysis indicated that this is based on an inverse correlation between viral loads 
and Gag-N-specific central memory CD28+ CD95+ CD8+ T-cell frequencies in LNs. These results strongly sup-
port a notion that CD8+ T cells targeting the N-terminal half of Gag antigen including most of the N-terminal 
domain of capsid (CA) (refs 31 and 32) exert strong suppressive pressure on SIV replication in LNs. CD8+ T-cell 
responses targeting more localized regions in Gag-N may be more strongly associated with lower viral loads. LNs 
without detectable p27 had significantly higher frequency Gag-N-specific CD28+ CD95+ CD8+ T cells than those 
with detectable p27. In the latter LNs with detectable p27, Gag-N-specific CD28−CD95+ CD8+ T cells, even if 
induced, might be consumed to fight against SIV-infected cells.
Analysis of LNs revealed a positive correlation between plasma viral loads and Env-N-specific CD8+ T-cell 
frequencies. Remarkably, frequencies of the Env-N-specific effector memory CD28−CD95+ subset in CD8+ T 
cells in LNs were correlated with viral loads. This correlation was found by analysis of LNs but not confirmed 
in PBMCs. LNs with detectable p27 had significantly higher frequency Env-N-specific CD28−CD95+ CD8+ T 
cells than those without detectable p27. Indeed, Env-N-specific CD28−CD95+ CD8+ T cells were positive in all 
the p27-positive LNs but negative in most of the p27-negative LNs. These results indicate that Env-N-specific 
Figure 5. Comparison of Gag-N- or Env-N-specific CD8+ T-cell frequencies between p27-positive and 
p27-negative LNs. (a) Immunostaining by anti-p27 antibody. Representative p27-positive (left panel) and 
p27-negative (right panel) results are shown. In the left panel, p27 was detected in the germinal center. (b) 
Comparisons of Gag-N-specific CD28+ CD95+ CD8+ T-cell frequencies (left panel) and Env-N-specific 
CD28−CD95+ CD8+ T-cell frequencies (right panel) in p27-positive (n = 9) and p27-negative (n = 7) LNs.  
LNs with detectable p27 had significantly lower Gag-N-specific CD28+ CD95+ CD8+ T-cell (p = 0.0323 
by Mann-Whitney U-test) and significantly higher Env-N-specific CD28−CD95+ CD8+ T-cell frequencies 
(p = 0.0086) than those without detectable p27.
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CD28−CD95+ CD8+ T-cell responses reflect SIV replication in LNs. This suggests a possibility that SIV replica-
tion results in induction of Env-N-specific CD8+ T-cell effectors, which fail to exert effector function to suppress 
viral replication and remain in LNs.
The present study indicates that induction of Env-N-specific CD8+ T cells in LNs does not contribute to 
suppression of SIV replication. We found association of viral loads with CD8+ T cells targeting the N-terminal 
half of Env including most of Env surface protein (SU, gp120) but not with those targeting the C-terminal 
half of Env including Env transmembrane protein (TM, gp41). Anti-SIV antibodies frequently target the for-
mer Env-N region, resulting in its higher diversity33,34. Thus, a possible explanation is that high diversity of 
Env-N-coding regions in viral genome may result in inefficient recognition and killing of target SIV-infected cells 
by Env-N-specific CD8+ T cells.
Our immunostaining detected SIV p27 antigens in the germinal center of the inguinal LNs. SIV-infected 
CD4+ T cells in the germinal center might have less chance to encounter SIV-specific CD8+ T cells compared to 
those in the paracortical area35. Then, it can be speculated that SIV replication in the germinal center that pro-
duces soluble gp120 antigens, resulting in induction of Env-N-specific CD8+ T cells in the paracortical area. This 
may also explain the association of Env-N-specific CD8+ T-cell responses with SIV replication in LNs.
In summary, we found an inverse correlation between plasma viral loads and Gag-N-specific central memory 
CD28+ CD95+ CD8+ T-cell frequencies. Furthermore, analysis of LNs revealed a positive correlation between 
viral loads and Env-N-specific effector memory CD28−CD95+ CD8+ T-cell frequencies in the chronic phase 
of SIV infection. LNs with detectable p27 antigen had lower Gag-N-specific CD28+ CD95+ CD8+ T-cell and 
higher Env-N-specific CD28−CD95+ CD8+ T-cell frequencies than those without detectable p27. These results 
suggest that core and envelope antigen-specific CD8+ T cells exhibit different patterns of interactions with HIV/
SIV-infected cells.
Methods
Animal experiments. We used twenty Burmese rhesus macaques (Macaca mulatta) chronically infected 
with SIV (Fig. 1a) for the present study. Seventeen macaques of the twenty had been used in our previous SIV 
challenge experiments20,36–41. Animals with varieties of MHC-I haplotypes including a protective MHC-I haplo-
type, 90-010-Id (D) (ref. 39), were used in this study. The determination of macaque MHC-I haplotypes was based 
on the family study in combination with the reference strand-mediated conformation analysis of Mamu-A and 
Mamu-B genes and detection of major Mamu-A and Mamu-B alleles by cloning the reverse transcription (RT)-
PCR products as described before42,43. Confirmed MHC-I alleles consisting of MHC-I haplotypes 90-120-Ia (A), 
90-120-Ib (B), D, 90-010-Ie (E), 90-030-Ih (H), and 89-002-Iq (Q) were described before38,43.
Of the twenty macaques, thirteen were unvaccinated and seven were vaccinated. Of the latter seven, three 
macaques possessing the MHC-I haplotype A, which is associated with dominant SIV Gag206–216- and Gag241–
249-specific CD8+ T-cell responses20,38, received a DNA prime followed by an intranasal boost with a Sendai 
virus (SeV) vector eliciting Gag241–249-specific CD8+ T-cell responses and one A-positive macaque received a 
DNA-prime/SeV-boost vaccine eliciting Gag206–216-specific CD8+ T-cell responses as described before36–37. 
The remaining three received a DNA prime followed by a boost with an SeV vector expressing SIVmac239 Gag 
(SeV-Gag) (ref. 20,40). After vaccination, one DNA/SeV-Gag-vaccinated macaque was intravenously challenged 
with an SIV that carries five gag mutations resulting in a L-to-S substitution at the 216th amino acid in Gag, a 
D-to-E at the 244th, an I-to-L at the 247th, an A-to-V at the 312th, and an A-to-T at the 373rd (ref. 20), while all 
other animals were intravenously challenged with the wild-type SIVmac239.
Animal experiments were carried out in the Institute for Virus Research, Kyoto University (IVRKU) and 
National Institute of Biomedical Innovation (NIBP; currently renamed National Institutes of Biomedical 
Innovation, Health and Nutrition [NIBIOHN]) with the help of the Corporation for Production and Research of 
Laboratory Primates after approval by the Committee on the Ethics of Animal Experiments of IVRKU and NIBP 
under the guideline for animal experiments at IVRKU, NIBP, and National Institute of Infectious Diseases, which 
is in accordance with the Guidelines for Proper Conduct of Animal Experiments established by Science Council 
of Japan (http://www.scj.go.jp/ja/info/kohyo/pdf/kohyo-20-k16-2e.pdf). Blood collection, vaccination, and SIV 
challenge were performed under ketamine anesthesia. Animals were euthanized at the end of experiments or at 
the endpoint determined by reduction in 10% loss of body weight, diarrhea, and general weakness. Animals with 
less than 200 cells/μ l of peripheral CD4+ T-cell counts were not included in this study. At euthanasia, animals 
were deeply anesthetized with pentobarbital under ketamine anesthesia, and then, whole blood was collected 
from left ventricle. The inguinal LNs were obtained at autopsy just after the euthanasia.
Analysis of antigen-specific CD8+ T-cell responses. We measured antigen-specific CD8+ T-cell 
responses by flow cytometric analysis detecting gamma interferon (IFN-γ ) induction after specific stimulation 
as described previously40. PBMCs or lymphocytes derived from the inguinal LNs were cocultured with autolo-
gous herpesvirus papio-immortalized B-lymphoblastoid cell lines (B-LCLs) pulsed with peptide pools (at a final 
concentration of 1 to 2 μ M for each peptide) using panels of overlapping peptides spanning the entire SIVmac239 
Gag-N (the N-terminal half of Gag [1st–265th amino acids]), Gag-C (the C-terminal half of Gag [255th–510th]), 
Pol-N (the N-terminal half of Pol [1st–531st]), Pol-C (the C-terminal half of Pol [521st–1060th]), Vif, Vpx, Vpr, 
Env-N (the N-terminal half of Env [1st–447th]), Env-C (the C-terminal half of Env [437th–879th]), Tat, Rev, 
and Nef amino acid sequences, respectively. Intracellular IFN-γ staining was performed with a CytofixCytoperm 
kit (BD) and fluorescein isothiocyanate (FITC)-conjugated anti-human CD4 (M-T477, BD), peridinin chloro-
phyll protein (PerCP)-conjugated anti-human CD8 (SK1, BD), allophycocyanin-Cy7 (APC-Cy7)-conjugated 
anti-human CD3 (SP34-2, BD), allophycocyanin (APC)-conjugated anti-human CD28 (CD28.2, Biolegend), 
phycoerythrin-Cy7 (PE-Cy7)-conjugated anti-human CD95 (DX2, eBioscience), and phycoerythrin 
(PE)-conjugated anti-human IFN-γ (4S.B3, Biolegend) monoclonal antibodies. Specific T-cell frequencies were 
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calculated by subtracting non-specific IFN-γ + T-cell frequencies from those after antigen-specific stimulation. 
As negative controls, we examined Gag-N- and Gag-C-specific CD8+ T-cell responses in eleven naive Burmese 
rhesus macaques. The “M + 2 × SD” value (where M is the mean and SD is the standard deviation) of these neg-
ative controls was 0.02% (of CD8+ T cells). Then, specific CD8+ T-cell frequencies lower than 0.02% of CD8+ T 
cells were considered negative.
Detection of viral antigen in the inguinal lymph nodes. Viral antigens (Gag capsid [CA] p27) in 
inguinal LNs were determined by immunohistochemistry using a rabbit anti-SIV Gag p27 polyclonal antibody 
(prepared by us) and an anti-rabbit immunoglobulin (EnVision/HRP, DAKO Cytomation) (ref. 44). The sections 
were counterstained with hematoxylin.
Statistical analysis. All statistical analyses were performed using Prism software version 4.03 (GraphPad 
Software, Inc.). Comparison of antigen-specific CD8+ T-cell frequencies was performed by Mann-Whitney 
U-test (significance levels set at P < 0.05). Correlation analysis was performed by Spearman’s test (significance 
levels set at P < 0.05).
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